Volume 15, Issue 5, Pages (September 2004)

Slides:



Advertisements
Similar presentations
Volume 11, Issue 4, Pages (April 2007)
Advertisements

UV as an Amplifier Rather Than Inducer of NF-κB Activity
Volume 145, Issue 2, Pages (August 2013)
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 9, Issue 5, Pages (November 1998)
Volume 11, Issue 6, Pages (June 2003)
PTF1α/p48 and cell proliferation
Volume 9, Issue 1, Pages (January 2002)
Siem van der Laan, Nikolay Tsanov, Carole Crozet, Domenico Maiorano 
Volume 57, Issue 3, Pages (February 2015)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Estela Jacinto, Guy Werlen, Michael Karin  Immunity 
The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo  Loning Fu, Helene Pelicano, Jinsong Liu, Peng.
Volume 16, Issue 1, Pages (October 2004)
Tie2-R849W Mutant in Venous Malformations Chronically Activates a Functional STAT1 to Modulate Gene Expression  Hsiao-Tang Hu, Yi-Hsien Huang, Yi-Ann.
Volume 44, Issue 3, Pages (November 2011)
Volume 23, Issue 1, Pages (July 2006)
Volume 18, Issue 3, Pages (April 2005)
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Volume 19, Issue 6, Pages (September 2005)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 145, Issue 2, Pages (August 2013)
Volume 5, Issue 4, Pages (April 2000)
The Mammalian UV Response
Volume 15, Issue 1, Pages (July 2004)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Coactivating Factors p300 and CBP Are Transcriptionally Crossregulated by Egr1 in Prostate Cells, Leading to Divergent Responses  Jianxiu Yu, Ian de Belle,
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 93, Issue 7, Pages (June 1998)
Xiaolong Wei, Hai Xu, Donald Kufe  Cancer Cell 
Volume 7, Issue 5, Pages (November 1997)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 17, Issue 1, Pages (January 2005)
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Volume 13, Issue 1, Pages (January 2008)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 16, Issue 24, Pages (December 2006)
Volume 56, Issue 5, Pages (December 2014)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
GSK-3-Mediated Phosphorylation Enhances Maf-Transforming Activity
JNK Regulates Autocrine Expression of TGF-β1
Volume 19, Issue 5, Pages (November 2003)
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 15, Issue 4, Pages (August 2004)
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Volume 96, Issue 6, Pages (March 1999)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 67, Issue 6, Pages (June 2005)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 125, Issue 4, Pages (May 2006)
1α,25-Dihydroxyvitamin D3 Stimulates Activator Protein 1 DNA-Binding Activity by a Phosphatidylinositol 3-Kinase/Ras/MEK/Extracellular Signal Regulated.
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Volume 12, Issue 5, Pages (November 2003)
Transcriptional Regulation of AKT Activation by E2F
NF-κB Is Required for UV-Induced JNK Activation via Induction of PKCδ
Volume 4, Issue 4, Pages (April 2015)
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Association of CNK1 with Rho Guanine Nucleotide Exchange Factors Controls Signaling Specificity Downstream of Rho  Aron B. Jaffe, Alan Hall, Anja Schmidt 
Volume 129, Issue 5, Pages (June 2007)
Volume 22, Issue 3, Pages (May 2006)
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 10, Issue 2, Pages (February 1999)
Chih-Yung S. Lee, Tzu-Lan Yeh, Bridget T. Hughes, Peter J. Espenshade 
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

Volume 15, Issue 5, Pages 713-725 (September 2004) Distinct Roles for JNK1 and JNK2 in Regulating JNK Activity and c-Jun-Dependent Cell Proliferation  Kanaga Sabapathy, Konrad Hochedlinger, Shin Yuen Nam, Anton Bauer, Michael Karin, Erwin F. Wagner  Molecular Cell  Volume 15, Issue 5, Pages 713-725 (September 2004) DOI: 10.1016/j.molcel.2004.08.028

Figure 1 JNK1 and JNK2 Differentially Regulate Cellular Proliferation (A) Primary MEFs or early passage 3T3 fibroblasts were labeled with BrdU and the BrdU+ cells were quantified by flow cytometry. Vertical bars represent the standard deviations. (B) Basal apoptotic rates were evaluated by determining the percentage of Annexin-V positive cells by flow cytometry. (C) Jnk2−/− fibroblasts exit the G1 phase of the cell cycle earlier. Various mutant 3T3 cells were labeled for an hour with BrdU and these cells were followed for the indicated periods of time to determine the percentage of BrdU-labeled cells in the S phase of the cell cycle. Arrows indicate time point at which cells exit the G1 phase of the cell cycle and re-enter the S phase. Molecular Cell 2004 15, 713-725DOI: (10.1016/j.molcel.2004.08.028)

Figure 2 JNK2 Negatively Regulates Proliferation of Erythroid Progenitors (A and B) Splenocytes from normal or anemic mice (PHZ–induced) were equally seeded on semi-solid media supporting either CFU-E (A) or BFU-E (B) formation. Representative photographs of colonies and colony numbers are shown. (C) Splenocytes were stained with antibodies to CD34 and c-Kit and analyzed by flow cytometry. At least four independent mice were used in each group. *, p < 0.01 by one-tail unpaired t test. Molecular Cell 2004 15, 713-725DOI: (10.1016/j.molcel.2004.08.028)

Figure 3 Increased Levels of Total and Phosphorylated c-Jun in Jnk2−/− Fibroblasts (A) Western blot analysis was performed on serum-starved or stimulated early passage 3T3 fibroblast extracts using the indicated antibodies. The relative levels of the indicated proteins (with respect to loading) were quantified by imaging and represented graphically. The levels of proteins from serum-starved wild-type cells were set as 1.0. (B) Northern blot analysis of c-jun, c-fos, and mkp-1 using total mRNA from serum-starved and released primary MEFs. (C) Levels of the indicated proteins were determined after UV irradiation. Molecular Cell 2004 15, 713-725DOI: (10.1016/j.molcel.2004.08.028)

Figure 4 Altered AP-1 Activity in JNK Mutant Cells (A) AP-1 transactivation assays were performed after transfections with the plasmid carrying the multimerized AP-1 consensus binding site (5 TRE) expressing the luciferase gene, and a plasmid expressing the β-galactosidase gene, and luciferase activity was measured 30 hr post transfection (left panel). Similarly, Jnk1−/−Jnk2−/− cells were transfected with the indicated plasmids, together with the 5× TRE plasmid and AP-1 activity was determined (right panel). Results are representative of three independent experiments. (B and C) MEFs were elutriated into fractions and their cell cycle status was determined by flow cytometry (A represents asynchronous cell culture). Extracts prepared from these cells (B) and from serum-starved and restimulated wild-type and Jnk2−/− 3T3 fibroblasts (C) were used for Western blot analysis. Molecular Cell 2004 15, 713-725DOI: (10.1016/j.molcel.2004.08.028)

Figure 5 c-Jun Kinase Activity Is Elevated and c-Jun Is More Stable in Jnk2−/− Fibroblasts (A) Extracts from serum-starved and released 3T3 cells were used to determine total c-Jun kinase activity by the solid-state kinase assay with GST-c-Jun as a substrate. The relative levels are represented graphically. (B) Total c-Jun kinase activity was determined after UV irradiation. Fold induction is indicated below. (C) Half-life of c-Jun. Cells were pulse-labeled with 35S-methionine for 1 hr and chased for the indicated periods of time. c-Jun-immunoprecipitated extracts were analyzed by SDS-PAGE and radioautography. Relative c-Jun levels are represented as percentage of total 35S-labeled c-Jun remaining, normalized to loading. Molecular Cell 2004 15, 713-725DOI: (10.1016/j.molcel.2004.08.028)

Figure 6 Re-Expression of JNK1 or JNK2 in Jnk2−/− Fibroblasts (A) Pools of Jnk2−/− early passage 3T3 fibroblasts stably transfected with either empty vector, HA-tagged Jnk1, or Jnk2 vectors were analyzed by Western blotting. (B) These cells were grown for the indicated time periods and cumulative cell numbers were determined. (C) Total c-Jun kinase activity and c-Jun levels were determined after UV irradiation. Molecular Cell 2004 15, 713-725DOI: (10.1016/j.molcel.2004.08.028)

Figure 7 Specific Binding of c-Jun to the JNKs (A) Untreated or UV-irradiated wild-type 3T3 fibroblasts were immunoprecipitated with anti-JNK1 or anti-JNK2 antibodies and c-Jun kinase activity in the immunocomplexes was determined. Western blot analysis was performed with the indicated antibodies. Blots were overexposed to detect the c-Jun-specific upshift. *, a nonspecific band. (B) Untreated or UV-irradiated wild-type, Jnk1−/− and Jnk2−/− 3T3 fibroblasts were immunoprecipitated with anti-c-Jun antibody and blots were immunodetected with the indicated antibodies. The relative levels of ubiquitin were quantified by imaging and represented graphically. The level of ubiquitin from untreated wild-type cells were set as 1.0. Molecular Cell 2004 15, 713-725DOI: (10.1016/j.molcel.2004.08.028)